Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/26/21 A | Tender | Director | 113,325 | 0.2916% | ||
| 1/26/21 A | Issuer sale | Director | 25,973 | 0.0668% | ||
| 1/26/21 A | Don | Chief Technology Officer | 366,525 | 0.9431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| -3.30% | +1.19% | +54.62% | +104.15% | 71.94B | |
| +1.13% | -3.14% | +39.92% | +76.87% | 59.35B | |
| +2.12% | +5.26% | +32.50% | +21.28% | 27.16B | |
| +2.71% | -1.96% | -13.79% | +364.46% | 26.54B | |
| +0.81% | +0.61% | -0.49% | -5.14% | 24.93B | |
| +0.62% | +1.15% | +23.40% | -9.32% | 20.61B | |
| -1.70% | -3.35% | +146.86% | +325.69% | 15.03B | |
| +0.21% | +1.17% | -8.07% | +499.10% | 14.2B | |
| +2.15% | -0.92% | +48.93% | +169.79% | 14.36B | |
| Average | -0.01% | -0.12% | +35.99% | +171.87% | 30.46B | |
| Weighted average by Cap. | -0.09% | -0.24% | +36.77% | +132.82% |
Employees
-
